<?xml version="1.0"?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2016//EN" "http://www.ncbi.nlm.nih.gov/corehtml/query/DTD/pubmed_160101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">27529637</PMID>
        <DateCreated>
            <Year>2016</Year>
            <Month>8</Month>
            <Day>16</Day>
        </DateCreated>
        <DateRevised>
            <Year>2016</Year>
            <Month>8</Month>
            <Day>16</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1520-5126</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2016</Year>
                        <Month>Aug</Month>
                        <Day>16</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of the American Chemical Society</Title>
                <ISOAbbreviation>J. Am. Chem. Soc.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Enzyme-Regulated Supramolecular Assemblies of Cholesterol Conjugates against Drug-Resistant Ovarian Cancer Cells.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNASSIGNED">We report that phosphotyrosine-cholesterol conjugates selectively kill cancer cells, including platinum-resistant ovarian cancer cells. Remarkably, the tyrosine-cholesterol conjugates exhibits higher potency and higher selectivity than cisplatin against drug-resistant human ovarian carcinoma cell lines (e.g., A2780cis) in cell assays. The conjugate increases the degree of non-covalent oligomerization upon enzymatic dephosphorylation in aqueous buffer. This enzymatic conversion of cholesterol conjugates also results in the assembly of the cholesterol conjugates inside and outside cells and leads to cell death. Moreover, preliminary mechanistic studies suggest that the formed assemblies of the conjugates not only interact with actin filaments and microtubules, but also affect lipid rafts. As the first report of multifaceted supramolecular assemblies of cholesterol conjugates against cancer cell, this work illustrates the integration of enzyme catalysis and self-assembly of essential biological small molecules on and inside cancer cells as a promising strategy for developing multifunctional therapeutics to treat drug-resistant cancers.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Huaimin</ForeName>
                    <Initials>H</Initials>
                </Author>
                <Author>
                    <LastName>Feng</LastName>
                    <ForeName>Zhaoqianqi</ForeName>
                    <Initials>Z</Initials>
                </Author>
                <Author>
                    <LastName>Wu</LastName>
                    <ForeName>Dongdong</ForeName>
                    <Initials>D</Initials>
                </Author>
                <Author>
                    <LastName>Fritzsching</LastName>
                    <ForeName>Keith J</ForeName>
                    <Initials>KJ</Initials>
                </Author>
                <Author>
                    <LastName>Rigney</LastName>
                    <ForeName>Mike</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Zhou</LastName>
                    <ForeName>Jie</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author>
                    <LastName>Jiang</LastName>
                    <ForeName>Yujie</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author>
                    <LastName>Schmidt-Rohr</LastName>
                    <ForeName>Klaus</ForeName>
                    <Initials>K</Initials>
                </Author>
                <Author>
                    <LastName>Xu</LastName>
                    <ForeName>Bing</ForeName>
                    <Initials>B</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType UI="">JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2016</Year>
                <Month>8</Month>
                <Day>16</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Am Chem Soc</MedlineTA>
            <NlmUniqueID>7503056</NlmUniqueID>
            <ISSNLinking>0002-7863</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2016</Year>
                <Month>8</Month>
                <Day>17</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2016</Year>
                <Month>8</Month>
                <Day>17</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2016</Year>
                <Month>8</Month>
                <Day>17</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1021/jacs.6b06075</ArticleId>
            <ArticleId IdType="pubmed">27529637</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>
